These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22628616)

  • 1. Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia.
    Arai K; Orsoni A; Mallat Z; Tedgui A; Witztum JL; Bruckert E; Tselepis AD; Chapman MJ; Tsimikas S
    J Lipid Res; 2012 Aug; 53(8):1670-8. PubMed ID: 22628616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a).
    Yeang C; Hung MY; Byun YS; Clopton P; Yang X; Witztum JL; Tsimikas S
    J Clin Lipidol; 2016; 10(3):594-603. PubMed ID: 27206947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.
    Rao F; Schork AJ; Maihofer AX; Nievergelt CM; Marcovina SM; Miller ER; Witztum JL; O'Connor DT; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1704-11. PubMed ID: 25953646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
    Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S
    J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
    Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
    Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
    Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S
    Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low-density lipoprotein apheresis on lipoprotein-associated phospholipase A2.
    Moriarty PM; Gibson CA
    Am J Cardiol; 2005 May; 95(10):1246-7. PubMed ID: 15878003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
    Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
    J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA₂.
    Tellis CC; Moutzouri E; Elisaf M; Wolfert RL; Tselepis AD
    J Lipid Res; 2013 Dec; 54(12):3394-402. PubMed ID: 24092915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized phospholipids in cardiovascular disease.
    Tsimikas S; Witztum JL
    Nat Rev Cardiol; 2024 Mar; 21(3):170-191. PubMed ID: 37848630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Lp-PLA(2) mass and apoB-lipoproteins that carry Lp-PLA(2) decrease after sodium.
    Constantinides A; Kerstens MN; Dikkeschei BD; van Pelt LJ; Tellis CC; Tselepis AD; Dullaart RP
    Eur J Clin Invest; 2012 Nov; 42(11):1235-43. PubMed ID: 22957745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes.
    Gilliland TC; Liu Y; Mohebi R; Miksenas H; Haidermota S; Wong M; Hu X; Cristino JR; Browne A; Plutzky J; Tsimikas S; Januzzi JL; Natarajan P
    J Am Coll Cardiol; 2023 May; 81(18):1780-1792. PubMed ID: 37137588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.
    Taleb A; Witztum JL; Tsimikas S
    Biomark Med; 2011 Oct; 5(5):673-94. PubMed ID: 22003918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles.
    Arai K; Luke MM; Koschinsky ML; Miller ER; Pullinger CR; Witztum JL; Kane JP; Tsimikas S
    Atherosclerosis; 2010 Apr; 209(2):498-503. PubMed ID: 19880117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study.
    Tsimikas S; Clopton P; Brilakis ES; Marcovina SM; Khera A; Miller ER; de Lemos JA; Witztum JL
    Circulation; 2009 Apr; 119(13):1711-9. PubMed ID: 19307470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.
    Capoulade R; Yeang C; Chan KL; Pibarot P; Tsimikas S
    JAMA Cardiol; 2018 Dec; 3(12):1212-1217. PubMed ID: 30476957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).
    Tsimikas S; Duff GW; Berger PB; Rogus J; Huttner K; Clopton P; Brilakis E; Kornman KS; Witztum JL
    J Am Coll Cardiol; 2014 May; 63(17):1724-34. PubMed ID: 24530664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
    Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
    J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.